Fostemsavir
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11796 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 43 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | homozygous familial hypercholesterolemia | KG + DL |
| 2 | HIV infectious disease | KG + DL |
| 3 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 4 | feline acquired immunodeficiency syndrome | KG + DL |
| 5 | simian immunodeficiency virus infection | KG + DL |
| 6 | obsolete familial combined hyperlipidemia | KG + DL |
| 7 | migraine disorder | KG + DL |
| 8 | Prinzmetal angina | KG + DL |
| 9 | gastrin secretion abnormality | KG + DL |
| 10 | multiple endocrine neoplasia | KG + DL |
| 11 | migraine with brainstem aura | KG + DL |
| 12 | thrombotic disease | KG + DL |
| 13 | hypoalphalipoproteinemia | KG + DL |
| 14 | rheumatoid arthritis | KG + DL |
| 15 | oral candidiasis | KG + DL |
| 16 | cytomegalovirus infection | KG + DL |
| 17 | commissural lip fistula | KG + DL |
| 18 | osteoradionecrosis of the mandible | KG + DL |
| 19 | oral leukoedema | KG + DL |
| 20 | burning mouth syndrome | KG + DL |
| 21 | coronary artery disease | KG + DL |
| 22 | abnormality of glucagon secretion | KG + DL |
| 23 | infectious bovine rhinotracheitis | KG + DL |
| 24 | malignant catarrh | KG + DL |
| 25 | gout | KG + DL |
| 26 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 27 | hyperthyroidism | KG + DL |
| 28 | Smouldering systemic mastocytosis | KG + DL |
| 29 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 30 | cerebral infarction | KG + DL |
| 31 | systemic mastocytosis | KG + DL |
| 32 | myocardial ischemia | KG + DL |
| 33 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 34 | anomalous left coronary artery from the pulmonary artery | KG + DL |
| 35 | duodenal obstruction | KG + DL |
| 36 | migraine with or without aura, susceptibility to | KG + DL |
| 37 | AIDS | KG + DL |
| 38 | duodenal ulcer (disease) | KG + DL |
| 39 | vein disease | KG + DL |
| 40 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 41 | brachydactyly-syndactyly syndrome | KG + DL |
| 42 | cerebral arterial disease | KG + DL |
| 43 | duodenogastric reflux | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.